poisar

Stock

Zenas BioPharma, Inc. ZBIO

$32.65-1.21%

Overview

ZBIO market data

Price History

ZBIO price chart · 1M
O
33.11
H
33.47
L
32.45
C
32.65
Vol
68,501.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$33.11
Previous Close
$33.05
Day High
$33.47
Day Low
$32.45
52 Week High
$34.02
52 Week Low
$16.44
7 Day Return
+3.37%
30 Day Return
+1.26%
90 Day Return
+77.51%
1 Year Return
+86.12%
Daily Notional Volume
$2.2M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$8.44
Diluted earnings per share over the trailing twelve months.
Beta
0.70
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-3,777.4%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$13.50 – $44.60
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $2B · P/B 8.05.

Company News

6 captured
Morgan Stanley Maintains Equal-Weight on Zenas BioPharma, Raises Price Target to $32Benzinga · Aug 14, 2026, 6:07 PM
Guggenheim Reiterates Buy on Zenas BioPharma, Maintains $55 Price TargetBenzinga · Aug 14, 2026, 1:37 PM
Wedbush Reiterates Outperform on Zenas BioPharma, Maintains $45 Price TargetBenzinga · Aug 14, 2026, 1:07 PM
Zenas BioPharma Q2 EPS $(1.77) Misses $(1.08) Estimate, Sales $1.000M Miss $18.750M EstimateBenzinga · Aug 13, 2026, 11:24 AM
8-K filing — Zenas BioPharma, Inc. (ZBIO)SEC EDGAR · Aug 13, 2026, 11:05 AM
Lennar Reports Mixed Q2 Results, Joins Adobe And Other Big Stocks Moving Lower In Friday's Pre-Market SessionBenzinga · Jun 12, 2026, 12:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock